These results indicated that rosuvastatin could suppress NLRP3 inflammasome activation and further inhibit pyroptosis in NP cells and that the inhibition of pyroptosis by rosuvastatin under inflammatory conditions might be a new strategy for treating IDD. Here, NLRP3 is linked to intervertebral disk degenerative disorder.